These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 4138246)

  • 1. Screening for disease: Definitions and criteria.
    Whitby LG
    Lancet; 1974 Oct; 2(7884):819-22. PubMed ID: 4138246
    [No Abstract]   [Full Text] [Related]  

  • 2. [Present status and problems of mass screening--from the viewpoint of public health].
    Miyake K
    Hokkaido Igaku Zasshi; 1986 Jul; 61(4):515-9. PubMed ID: 3093347
    [No Abstract]   [Full Text] [Related]  

  • 3. On improving the diagnostic value of quantitative medical laboratory tests in health screening.
    Weldon KL; MacKay JS
    J Chronic Dis; 1972 Dec; 25(12):697-709. PubMed ID: 4648514
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiphasic screening.
    Knox EG
    Lancet; 1974 Dec; 2(7894):1434-6. PubMed ID: 4140342
    [No Abstract]   [Full Text] [Related]  

  • 5. Terminology of false negative and false positive Pap smears: "They're just worms".
    Naryshkin S; Davey DD
    Diagn Cytopathol; 1996 Feb; 14(1):1-3. PubMed ID: 8834068
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening yield in an urban low income practice.
    Coulehan JL
    Am J Public Health; 1975 May; 65(5):474-9. PubMed ID: 1130569
    [No Abstract]   [Full Text] [Related]  

  • 7. Reporting the assessment of screening and diagnostic tests.
    Wald N; Cuckle H
    Br J Obstet Gynaecol; 1989 Apr; 96(4):389-96. PubMed ID: 2751951
    [No Abstract]   [Full Text] [Related]  

  • 8. Value of new laboratory tests in diagnosis and treatment.
    Holland WW; Whitehead TP
    Lancet; 1974 Aug; 2(7877):391-4. PubMed ID: 4137352
    [No Abstract]   [Full Text] [Related]  

  • 9. Understanding laboratory test results. Conditions for appropriate use of laboratory tests.
    Schwartz JS
    Med Clin North Am; 1987 Jul; 71(4):639-52. PubMed ID: 3295419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for false positive and for false negative test results in screening with fecal occult blood testing.
    Stegeman I; de Wijkerslooth TR; Stoop EM; van Leerdam M; van Ballegooijen M; Kraaijenhagen RA; Fockens P; Kuipers EJ; Dekker E; Bossuyt PM
    Int J Cancer; 2013 Nov; 133(10):2408-14. PubMed ID: 23649826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory closure of cervical cytology laboratories: recommendations for a public health response.
    MMWR Recomm Rep; 1997 Dec; 46(RR-17):1-19. PubMed ID: 9409538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Industrial employee drug screening: a blind study of laboratory performance using commercially prepared controls.
    Knight SJ; Freedman T; Puskas A; Martel PA; O'Donnell CM
    J Occup Med; 1990 Aug; 32(8):715-21. PubMed ID: 2401928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The medical check-up.
    Bayliss RI
    Br Med J (Clin Res Ed); 1981 Sep; 283(6292):631-4. PubMed ID: 6790109
    [No Abstract]   [Full Text] [Related]  

  • 14. Medicolegal affairs. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
    Frable WJ; Austin RM; Greening SE; Collins RJ; Hillman RL; Kobler TP; Koss LG; Mitchell H; Perey R; Rosenthal DL; Sidoti MS; Somrak TM
    Acta Cytol; 1998; 42(1):76-119; discussion 120-32. PubMed ID: 9479326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiphasic health screening.
    Rowe IL
    Med J Aust; 1972 Dec; 2(23):1319-20. PubMed ID: 4675261
    [No Abstract]   [Full Text] [Related]  

  • 16. False-negative results in screening programmes: systematic review of impact and implications.
    Petticrew MP; Sowden AJ; Lister-Sharp D; Wright K
    Health Technol Assess; 2000; 4(5):1-120. PubMed ID: 10859208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The false-negative fraction: a statistical method to measure the efficacy of cervical smear screening laboratories.
    Dolinar J; Ollayos CW; Tellado M; Ali I; Stevens A; Paquette C; Brodbelt S
    Mil Med; 1999 Jun; 164(6):410-1. PubMed ID: 10377709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiphasic screening by laboratory tests--an overview of the problem.
    Barnett RN; Civin WH; Schoen I
    Am J Clin Pathol; 1970 Sep; 54(3):483-92. PubMed ID: 5459734
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluating the national screening programme for congenital dislocation of the hip.
    Dezateux C; Godward S
    J Med Screen; 1995; 2(4):200-6. PubMed ID: 8719149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical cancer screening programs. II. Screening for carcinoma of the cervix.
    Can Med Assoc J; 1976 Jun; 114(11):1013-26. PubMed ID: 776379
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.